NW
GILD icon

NewEdge Wealth’s Gilead Sciences GILD Stock Holding History

NewEdge Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.3M Buy
754,019
+47,294
+7% +$6.23M 0.95% 18
2026
Q1 		$98.5M Buy
706,725
+60,255
+9% +$8.44M 1.17% 14
2025
Q4 		$79.3M Buy
646,470
+26,780
+4% +$3.25M 0.9% 17
2025
Q3 		$76M Buy
619,690
+17,284
+3% +$1.96M 1.09% 12
2025
Q2 		$66.4M Buy
602,406
+170,165
+39% +$18.1M 1.04% 15
2025
Q1 		$48.4M Buy
432,241
+27,424
+7% +$2.83M 0.88% 21
2024
Q4 		$37.4M Buy
404,817
+30,243
+8% +$2.72M 0.65% 36
2024
Q3 		$31.4M Buy
374,574
+4,087
+1% +$312K 0.57% 42
2024
Q2 		$25.4M Sell
370,487
-6,943
-2% -$463K 0.55% 47
2024
Q1 		$24.7M Buy
377,430
+37,463
+11% +$2.88M 0.55% 44
2023
Q4 		$27.5M Buy
339,967
+27,572
+9% +$2.15M 0.7% 34
2023
Q3 		$23.4M Buy
312,395
+47,137
+18% +$3.63M 0.74% 32
2023
Q2 		$20.4M Buy
265,258
+81,231
+44% +$6.48M 0.68% 34
2023
Q1 		$15.3M Buy
184,027
+97,736
+113% +$8.09M 0.58% 49
2022
Q4 		$7.41M Buy
86,291
+3,874
+5% +$307K 0.32% 89
2022
Q3 		$5.08M Sell
82,417
-23,415
-22% -$1.48M 0.24% 101
2022
Q2 		$6.54M Buy
105,832
+33,126
+46% +$2.05M 0.3% 87
2022
Q1 		$4.32M Buy
72,706
+6,129
+9% +$392K 0.19% 117
2021
Q4 		$4.83M Buy
66,577
+5,011
+8% +$345K 0.2% 112
2021
Q3 		$4.3M Buy
+61,566
New +$4.33M 0.26% 90

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NewEdge Wealth's GILD Position: Q2 2026 in Review

NewEdge Wealth increased its Gilead Sciences (GILD) stake by 6.7% in Q2 2026, buying an estimated $6.23M and bringing the position to 754,019 shares worth $95.3M. The position accounts for 0.95% of the portfolio, ranked #18.

NewEdge Wealth first reported a position in GILD in Q3 2021 and has held it in 20 quarters since. The position peaked at $98.5M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • NewEdge Wealth held 754,019 shares of Gilead Sciences worth $95.3M as of Q2 2026.
  • NewEdge Wealth bought 47,294 Gilead Sciences shares in Q2 2026, an estimated $6.23M.
  • Gilead Sciences made up 0.95% of NewEdge Wealth's portfolio in Q2 2026, its #18 holding.
  • NewEdge Wealth first reported a position in Gilead Sciences in Q3 2021 and has held it in 20 quarters since.
  • NewEdge Wealth's Gilead Sciences position peaked at $98.5M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.